Invention Grant
- Patent Title: Glioblastoma inhibiting compounds and their use
- Patent Title (中): 成胶质细胞瘤抑制化合物及其用途
-
Application No.: US14126512Application Date: 2012-06-15
-
Publication No.: US09573960B2Publication Date: 2017-02-21
- Inventor: Björn Scheffler , Martin Glas , Matthias Simon , Sabine Gogolok , Daniel Trageser , Roman Reinartz , Anja Wieland
- Applicant: Björn Scheffler , Martin Glas , Matthias Simon , Sabine Gogolok , Daniel Trageser , Roman Reinartz , Anja Wieland
- Applicant Address: DE Bonn DE Bonn
- Assignee: Life & Brain GmbH,Rheinische Friedrich-Wilhelms Universitat
- Current Assignee: Life & Brain GmbH,Rheinische Friedrich-Wilhelms Universitat
- Current Assignee Address: DE Bonn DE Bonn
- Agency: Barnes & Thornburg LLP
- International Application: PCT/EP2012/061485 WO 20120615
- International Announcement: WO2012/172069 WO 20121220
- Main IPC: C07D493/06
- IPC: C07D493/06 ; C07D493/18 ; A61K31/352 ; G01N33/574 ; A61K31/4188
Abstract:
The present invention relates to glioblastoma inhibiting compounds, in particular gambogic acid amid and derivatives thereof for the treatment of glioblastoma. Moreover, methods for determining whether a treatment with the compounds of the invention is suitable for a patient are disclosed.
Public/Granted literature
- US20150148390A1 GLIOBLASTOMA INHIBITING COMPOUNDS AND THEIR USE Public/Granted day:2015-05-28
Information query
